nodes	percent_of_prediction	percent_of_DWPC	metapath
Letrozole—CYP3A4—type 2 diabetes mellitus	0.297	1	CbGaD
Letrozole—CYP2A6—Rosiglitazone—type 2 diabetes mellitus	0.13	0.312	CbGbCtD
Letrozole—CYP3A4—Linagliptin—type 2 diabetes mellitus	0.0437	0.105	CbGbCtD
Letrozole—CYP3A4—Sitagliptin—type 2 diabetes mellitus	0.0389	0.0935	CbGbCtD
Letrozole—CYP3A4—Glipizide—type 2 diabetes mellitus	0.0356	0.0855	CbGbCtD
Letrozole—CYP3A4—Repaglinide—type 2 diabetes mellitus	0.0311	0.0747	CbGbCtD
Letrozole—CYP3A4—Pioglitazone—type 2 diabetes mellitus	0.0281	0.0676	CbGbCtD
Letrozole—CYP3A4—Nateglinide—type 2 diabetes mellitus	0.0213	0.0512	CbGbCtD
Letrozole—CYP3A4—Irbesartan—type 2 diabetes mellitus	0.0204	0.0491	CbGbCtD
Letrozole—CYP3A4—Orlistat—type 2 diabetes mellitus	0.0204	0.0491	CbGbCtD
Letrozole—CYP3A4—Bromocriptine—type 2 diabetes mellitus	0.0193	0.0464	CbGbCtD
Letrozole—CYP3A4—Glyburide—type 2 diabetes mellitus	0.0144	0.0346	CbGbCtD
Letrozole—CYP3A4—Losartan—type 2 diabetes mellitus	0.0132	0.0316	CbGbCtD
Letrozole—Bifonazole—CYP2E1—type 2 diabetes mellitus	0.000828	0.614	CrCbGaD
Letrozole—Bifonazole—CYP3A4—type 2 diabetes mellitus	0.000521	0.386	CrCbGaD
Letrozole—Pain—Gliclazide—type 2 diabetes mellitus	0.00013	0.000562	CcSEcCtD
Letrozole—Constipation—Gliclazide—type 2 diabetes mellitus	0.00013	0.000562	CcSEcCtD
Letrozole—Rash—Glimepiride—type 2 diabetes mellitus	0.00013	0.00056	CcSEcCtD
Letrozole—Dermatitis—Glimepiride—type 2 diabetes mellitus	0.00013	0.00056	CcSEcCtD
Letrozole—Rash—Sitagliptin—type 2 diabetes mellitus	0.000129	0.000558	CcSEcCtD
Letrozole—Dermatitis—Sitagliptin—type 2 diabetes mellitus	0.000129	0.000558	CcSEcCtD
Letrozole—Erythema multiforme—Ramipril—type 2 diabetes mellitus	0.000129	0.000558	CcSEcCtD
Letrozole—Headache—Glimepiride—type 2 diabetes mellitus	0.000129	0.000556	CcSEcCtD
Letrozole—Ill-defined disorder—Losartan—type 2 diabetes mellitus	0.000129	0.000556	CcSEcCtD
Letrozole—Cough—Irbesartan—type 2 diabetes mellitus	0.000129	0.000555	CcSEcCtD
Letrozole—Headache—Sitagliptin—type 2 diabetes mellitus	0.000128	0.000555	CcSEcCtD
Letrozole—Musculoskeletal discomfort—Valsartan—type 2 diabetes mellitus	0.000127	0.000551	CcSEcCtD
Letrozole—Oedema—Metformin—type 2 diabetes mellitus	0.000127	0.00055	CcSEcCtD
Letrozole—Hypertension—Irbesartan—type 2 diabetes mellitus	0.000127	0.000549	CcSEcCtD
Letrozole—Diarrhoea—Bromocriptine—type 2 diabetes mellitus	0.000127	0.000548	CcSEcCtD
Letrozole—Flushing—Ramipril—type 2 diabetes mellitus	0.000127	0.000547	CcSEcCtD
Letrozole—Angioedema—Losartan—type 2 diabetes mellitus	0.000127	0.000547	CcSEcCtD
Letrozole—Infection—Metformin—type 2 diabetes mellitus	0.000127	0.000547	CcSEcCtD
Letrozole—Insomnia—Valsartan—type 2 diabetes mellitus	0.000127	0.000547	CcSEcCtD
Letrozole—Musculoskeletal discomfort—Orlistat—type 2 diabetes mellitus	0.000126	0.000544	CcSEcCtD
Letrozole—Paraesthesia—Valsartan—type 2 diabetes mellitus	0.000126	0.000543	CcSEcCtD
Letrozole—Feeling abnormal—Gliclazide—type 2 diabetes mellitus	0.000125	0.000542	CcSEcCtD
Letrozole—Myalgia—Irbesartan—type 2 diabetes mellitus	0.000125	0.000542	CcSEcCtD
Letrozole—Arthralgia—Irbesartan—type 2 diabetes mellitus	0.000125	0.000542	CcSEcCtD
Letrozole—Chest pain—Irbesartan—type 2 diabetes mellitus	0.000125	0.000542	CcSEcCtD
Letrozole—Insomnia—Orlistat—type 2 diabetes mellitus	0.000125	0.00054	CcSEcCtD
Letrozole—Malaise—Losartan—type 2 diabetes mellitus	0.000125	0.00054	CcSEcCtD
Letrozole—Anxiety—Irbesartan—type 2 diabetes mellitus	0.000125	0.00054	CcSEcCtD
Letrozole—Nervous system disorder—Metformin—type 2 diabetes mellitus	0.000125	0.00054	CcSEcCtD
Letrozole—Dyspnoea—Valsartan—type 2 diabetes mellitus	0.000125	0.000539	CcSEcCtD
Letrozole—Vertigo—Losartan—type 2 diabetes mellitus	0.000125	0.000538	CcSEcCtD
Letrozole—Unspecified disorder of skin and subcutaneous tissue—Irbesartan—type 2 diabetes mellitus	0.000125	0.000538	CcSEcCtD
Letrozole—Gastrointestinal pain—Gliclazide—type 2 diabetes mellitus	0.000125	0.000538	CcSEcCtD
Letrozole—Somnolence—Valsartan—type 2 diabetes mellitus	0.000124	0.000537	CcSEcCtD
Letrozole—Paraesthesia—Orlistat—type 2 diabetes mellitus	0.000124	0.000536	CcSEcCtD
Letrozole—Leukopenia—Losartan—type 2 diabetes mellitus	0.000124	0.000536	CcSEcCtD
Letrozole—Discomfort—Irbesartan—type 2 diabetes mellitus	0.000124	0.000535	CcSEcCtD
Letrozole—Skin disorder—Metformin—type 2 diabetes mellitus	0.000124	0.000535	CcSEcCtD
Letrozole—Hyperhidrosis—Metformin—type 2 diabetes mellitus	0.000123	0.000532	CcSEcCtD
Letrozole—Dyspepsia—Valsartan—type 2 diabetes mellitus	0.000123	0.000532	CcSEcCtD
Letrozole—Mediastinal disorder—Ramipril—type 2 diabetes mellitus	0.000123	0.000532	CcSEcCtD
Letrozole—Dizziness—Bromocriptine—type 2 diabetes mellitus	0.000123	0.00053	CcSEcCtD
Letrozole—Dry mouth—Irbesartan—type 2 diabetes mellitus	0.000123	0.00053	CcSEcCtD
Letrozole—Palpitations—Losartan—type 2 diabetes mellitus	0.000123	0.000529	CcSEcCtD
Letrozole—Nausea—Glimepiride—type 2 diabetes mellitus	0.000122	0.000528	CcSEcCtD
Letrozole—Nausea—Sitagliptin—type 2 diabetes mellitus	0.000122	0.000526	CcSEcCtD
Letrozole—Dyspepsia—Orlistat—type 2 diabetes mellitus	0.000122	0.000526	CcSEcCtD
Letrozole—Asthenia—Glyburide—type 2 diabetes mellitus	0.000122	0.000526	CcSEcCtD
Letrozole—Decreased appetite—Valsartan—type 2 diabetes mellitus	0.000122	0.000525	CcSEcCtD
Letrozole—Anorexia—Metformin—type 2 diabetes mellitus	0.000121	0.000525	CcSEcCtD
Letrozole—Cough—Losartan—type 2 diabetes mellitus	0.000121	0.000523	CcSEcCtD
Letrozole—Urticaria—Gliclazide—type 2 diabetes mellitus	0.000121	0.000523	CcSEcCtD
Letrozole—Gastrointestinal disorder—Valsartan—type 2 diabetes mellitus	0.000121	0.000522	CcSEcCtD
Letrozole—Alopecia—Ramipril—type 2 diabetes mellitus	0.000121	0.000521	CcSEcCtD
Letrozole—Fatigue—Valsartan—type 2 diabetes mellitus	0.000121	0.000521	CcSEcCtD
Letrozole—Body temperature increased—Gliclazide—type 2 diabetes mellitus	0.00012	0.00052	CcSEcCtD
Letrozole—Abdominal pain—Gliclazide—type 2 diabetes mellitus	0.00012	0.00052	CcSEcCtD
Letrozole—Anaphylactic shock—Irbesartan—type 2 diabetes mellitus	0.00012	0.000519	CcSEcCtD
Letrozole—Oedema—Irbesartan—type 2 diabetes mellitus	0.00012	0.000519	CcSEcCtD
Letrozole—Decreased appetite—Orlistat—type 2 diabetes mellitus	0.00012	0.000519	CcSEcCtD
Letrozole—Pruritus—Glyburide—type 2 diabetes mellitus	0.00012	0.000518	CcSEcCtD
Letrozole—Mental disorder—Ramipril—type 2 diabetes mellitus	0.00012	0.000517	CcSEcCtD
Letrozole—Constipation—Valsartan—type 2 diabetes mellitus	0.00012	0.000517	CcSEcCtD
Letrozole—Infection—Irbesartan—type 2 diabetes mellitus	0.000119	0.000516	CcSEcCtD
Letrozole—Gastrointestinal disorder—Orlistat—type 2 diabetes mellitus	0.000119	0.000516	CcSEcCtD
Letrozole—Fatigue—Orlistat—type 2 diabetes mellitus	0.000119	0.000515	CcSEcCtD
Letrozole—Malnutrition—Ramipril—type 2 diabetes mellitus	0.000119	0.000514	CcSEcCtD
Letrozole—Pain—Orlistat—type 2 diabetes mellitus	0.000118	0.000511	CcSEcCtD
Letrozole—Chest pain—Losartan—type 2 diabetes mellitus	0.000118	0.00051	CcSEcCtD
Letrozole—Arthralgia—Losartan—type 2 diabetes mellitus	0.000118	0.00051	CcSEcCtD
Letrozole—Myalgia—Losartan—type 2 diabetes mellitus	0.000118	0.00051	CcSEcCtD
Letrozole—Vomiting—Bromocriptine—type 2 diabetes mellitus	0.000118	0.000509	CcSEcCtD
Letrozole—Nervous system disorder—Irbesartan—type 2 diabetes mellitus	0.000118	0.000509	CcSEcCtD
Letrozole—Anxiety—Losartan—type 2 diabetes mellitus	0.000118	0.000508	CcSEcCtD
Letrozole—Tachycardia—Irbesartan—type 2 diabetes mellitus	0.000117	0.000507	CcSEcCtD
Letrozole—Rash—Bromocriptine—type 2 diabetes mellitus	0.000117	0.000505	CcSEcCtD
Letrozole—Dermatitis—Bromocriptine—type 2 diabetes mellitus	0.000117	0.000505	CcSEcCtD
Letrozole—Skin disorder—Irbesartan—type 2 diabetes mellitus	0.000117	0.000504	CcSEcCtD
Letrozole—Tension—Ramipril—type 2 diabetes mellitus	0.000117	0.000504	CcSEcCtD
Letrozole—Discomfort—Losartan—type 2 diabetes mellitus	0.000117	0.000504	CcSEcCtD
Letrozole—Dysgeusia—Ramipril—type 2 diabetes mellitus	0.000116	0.000503	CcSEcCtD
Letrozole—Hyperhidrosis—Irbesartan—type 2 diabetes mellitus	0.000116	0.000502	CcSEcCtD
Letrozole—Headache—Bromocriptine—type 2 diabetes mellitus	0.000116	0.000502	CcSEcCtD
Letrozole—Musculoskeletal discomfort—Metformin—type 2 diabetes mellitus	0.000116	0.000501	CcSEcCtD
Letrozole—Diarrhoea—Glyburide—type 2 diabetes mellitus	0.000116	0.000501	CcSEcCtD
Letrozole—Nervousness—Ramipril—type 2 diabetes mellitus	0.000115	0.000499	CcSEcCtD
Letrozole—Dry mouth—Losartan—type 2 diabetes mellitus	0.000115	0.000499	CcSEcCtD
Letrozole—Anorexia—Irbesartan—type 2 diabetes mellitus	0.000115	0.000495	CcSEcCtD
Letrozole—Gastrointestinal pain—Valsartan—type 2 diabetes mellitus	0.000114	0.000494	CcSEcCtD
Letrozole—Paraesthesia—Metformin—type 2 diabetes mellitus	0.000114	0.000494	CcSEcCtD
Letrozole—Feeling abnormal—Orlistat—type 2 diabetes mellitus	0.000114	0.000492	CcSEcCtD
Letrozole—Dyspnoea—Metformin—type 2 diabetes mellitus	0.000114	0.000491	CcSEcCtD
Letrozole—Somnolence—Metformin—type 2 diabetes mellitus	0.000113	0.000489	CcSEcCtD
Letrozole—Anaphylactic shock—Losartan—type 2 diabetes mellitus	0.000113	0.000489	CcSEcCtD
Letrozole—Oedema—Losartan—type 2 diabetes mellitus	0.000113	0.000489	CcSEcCtD
Letrozole—Gastrointestinal pain—Orlistat—type 2 diabetes mellitus	0.000113	0.000488	CcSEcCtD
Letrozole—Infection—Losartan—type 2 diabetes mellitus	0.000112	0.000486	CcSEcCtD
Letrozole—Dyspepsia—Metformin—type 2 diabetes mellitus	0.000112	0.000484	CcSEcCtD
Letrozole—Urticaria—Valsartan—type 2 diabetes mellitus	0.000111	0.00048	CcSEcCtD
Letrozole—Nervous system disorder—Losartan—type 2 diabetes mellitus	0.000111	0.000479	CcSEcCtD
Letrozole—Decreased appetite—Metformin—type 2 diabetes mellitus	0.000111	0.000478	CcSEcCtD
Letrozole—Abdominal pain—Valsartan—type 2 diabetes mellitus	0.000111	0.000478	CcSEcCtD
Letrozole—Tachycardia—Losartan—type 2 diabetes mellitus	0.00011	0.000477	CcSEcCtD
Letrozole—Ill-defined disorder—Ramipril—type 2 diabetes mellitus	0.00011	0.000476	CcSEcCtD
Letrozole—Nausea—Bromocriptine—type 2 diabetes mellitus	0.00011	0.000476	CcSEcCtD
Letrozole—Gastrointestinal disorder—Metformin—type 2 diabetes mellitus	0.00011	0.000475	CcSEcCtD
Letrozole—Fatigue—Metformin—type 2 diabetes mellitus	0.00011	0.000474	CcSEcCtD
Letrozole—Urticaria—Orlistat—type 2 diabetes mellitus	0.00011	0.000474	CcSEcCtD
Letrozole—Musculoskeletal discomfort—Irbesartan—type 2 diabetes mellitus	0.00011	0.000473	CcSEcCtD
Letrozole—Hyperhidrosis—Losartan—type 2 diabetes mellitus	0.000109	0.000472	CcSEcCtD
Letrozole—Body temperature increased—Orlistat—type 2 diabetes mellitus	0.000109	0.000472	CcSEcCtD
Letrozole—Abdominal pain—Orlistat—type 2 diabetes mellitus	0.000109	0.000472	CcSEcCtD
Letrozole—Asthenia—Gliclazide—type 2 diabetes mellitus	0.000109	0.000472	CcSEcCtD
Letrozole—Constipation—Metformin—type 2 diabetes mellitus	0.000109	0.000471	CcSEcCtD
Letrozole—Angioedema—Ramipril—type 2 diabetes mellitus	0.000109	0.000469	CcSEcCtD
Letrozole—Paraesthesia—Irbesartan—type 2 diabetes mellitus	0.000108	0.000466	CcSEcCtD
Letrozole—Anorexia—Losartan—type 2 diabetes mellitus	0.000108	0.000466	CcSEcCtD
Letrozole—Vomiting—Glyburide—type 2 diabetes mellitus	0.000108	0.000466	CcSEcCtD
Letrozole—Pruritus—Gliclazide—type 2 diabetes mellitus	0.000108	0.000465	CcSEcCtD
Letrozole—Malaise—Ramipril—type 2 diabetes mellitus	0.000107	0.000463	CcSEcCtD
Letrozole—Dyspnoea—Irbesartan—type 2 diabetes mellitus	0.000107	0.000463	CcSEcCtD
Letrozole—Rash—Glyburide—type 2 diabetes mellitus	0.000107	0.000462	CcSEcCtD
Letrozole—Somnolence—Irbesartan—type 2 diabetes mellitus	0.000107	0.000462	CcSEcCtD
Letrozole—Dermatitis—Glyburide—type 2 diabetes mellitus	0.000107	0.000461	CcSEcCtD
Letrozole—Vertigo—Ramipril—type 2 diabetes mellitus	0.000107	0.000461	CcSEcCtD
Letrozole—Leukopenia—Ramipril—type 2 diabetes mellitus	0.000106	0.00046	CcSEcCtD
Letrozole—Headache—Glyburide—type 2 diabetes mellitus	0.000106	0.000459	CcSEcCtD
Letrozole—Dyspepsia—Irbesartan—type 2 diabetes mellitus	0.000106	0.000457	CcSEcCtD
Letrozole—Palpitations—Ramipril—type 2 diabetes mellitus	0.000105	0.000454	CcSEcCtD
Letrozole—Feeling abnormal—Metformin—type 2 diabetes mellitus	0.000105	0.000454	CcSEcCtD
Letrozole—Decreased appetite—Irbesartan—type 2 diabetes mellitus	0.000105	0.000451	CcSEcCtD
Letrozole—Diarrhoea—Gliclazide—type 2 diabetes mellitus	0.000104	0.00045	CcSEcCtD
Letrozole—Gastrointestinal pain—Metformin—type 2 diabetes mellitus	0.000104	0.00045	CcSEcCtD
Letrozole—Gastrointestinal disorder—Irbesartan—type 2 diabetes mellitus	0.000104	0.000448	CcSEcCtD
Letrozole—Cough—Ramipril—type 2 diabetes mellitus	0.000104	0.000448	CcSEcCtD
Letrozole—Fatigue—Irbesartan—type 2 diabetes mellitus	0.000104	0.000448	CcSEcCtD
Letrozole—Musculoskeletal discomfort—Losartan—type 2 diabetes mellitus	0.000103	0.000445	CcSEcCtD
Letrozole—Pain—Irbesartan—type 2 diabetes mellitus	0.000103	0.000444	CcSEcCtD
Letrozole—Constipation—Irbesartan—type 2 diabetes mellitus	0.000103	0.000444	CcSEcCtD
Letrozole—Insomnia—Losartan—type 2 diabetes mellitus	0.000102	0.000442	CcSEcCtD
Letrozole—Paraesthesia—Losartan—type 2 diabetes mellitus	0.000102	0.000439	CcSEcCtD
Letrozole—Urticaria—Metformin—type 2 diabetes mellitus	0.000101	0.000437	CcSEcCtD
Letrozole—Arthralgia—Ramipril—type 2 diabetes mellitus	0.000101	0.000437	CcSEcCtD
Letrozole—Chest pain—Ramipril—type 2 diabetes mellitus	0.000101	0.000437	CcSEcCtD
Letrozole—Myalgia—Ramipril—type 2 diabetes mellitus	0.000101	0.000437	CcSEcCtD
Letrozole—Dyspnoea—Losartan—type 2 diabetes mellitus	0.000101	0.000436	CcSEcCtD
Letrozole—Anxiety—Ramipril—type 2 diabetes mellitus	0.000101	0.000436	CcSEcCtD
Letrozole—Nausea—Glyburide—type 2 diabetes mellitus	0.000101	0.000435	CcSEcCtD
Letrozole—Abdominal pain—Metformin—type 2 diabetes mellitus	0.000101	0.000435	CcSEcCtD
Letrozole—Dizziness—Gliclazide—type 2 diabetes mellitus	0.000101	0.000435	CcSEcCtD
Letrozole—Somnolence—Losartan—type 2 diabetes mellitus	0.000101	0.000435	CcSEcCtD
Letrozole—Unspecified disorder of skin and subcutaneous tissue—Ramipril—type 2 diabetes mellitus	0.000101	0.000434	CcSEcCtD
Letrozole—Asthenia—Valsartan—type 2 diabetes mellitus	0.0001	0.000434	CcSEcCtD
Letrozole—Discomfort—Ramipril—type 2 diabetes mellitus	0.0001	0.000432	CcSEcCtD
Letrozole—Dyspepsia—Losartan—type 2 diabetes mellitus	9.96e-05	0.00043	CcSEcCtD
Letrozole—Asthenia—Orlistat—type 2 diabetes mellitus	9.92e-05	0.000428	CcSEcCtD
Letrozole—Feeling abnormal—Irbesartan—type 2 diabetes mellitus	9.91e-05	0.000428	CcSEcCtD
Letrozole—Pruritus—Valsartan—type 2 diabetes mellitus	9.9e-05	0.000428	CcSEcCtD
Letrozole—Dry mouth—Ramipril—type 2 diabetes mellitus	9.9e-05	0.000428	CcSEcCtD
Letrozole—Decreased appetite—Losartan—type 2 diabetes mellitus	9.84e-05	0.000425	CcSEcCtD
Letrozole—Gastrointestinal pain—Irbesartan—type 2 diabetes mellitus	9.83e-05	0.000425	CcSEcCtD
Letrozole—Pruritus—Orlistat—type 2 diabetes mellitus	9.78e-05	0.000422	CcSEcCtD
Letrozole—Fatigue—Losartan—type 2 diabetes mellitus	9.76e-05	0.000421	CcSEcCtD
Letrozole—Oedema—Ramipril—type 2 diabetes mellitus	9.7e-05	0.000419	CcSEcCtD
Letrozole—Anaphylactic shock—Ramipril—type 2 diabetes mellitus	9.7e-05	0.000419	CcSEcCtD
Letrozole—Vomiting—Gliclazide—type 2 diabetes mellitus	9.68e-05	0.000418	CcSEcCtD
Letrozole—Pain—Losartan—type 2 diabetes mellitus	9.68e-05	0.000418	CcSEcCtD
Letrozole—Constipation—Losartan—type 2 diabetes mellitus	9.68e-05	0.000418	CcSEcCtD
Letrozole—Rash—Gliclazide—type 2 diabetes mellitus	9.6e-05	0.000415	CcSEcCtD
Letrozole—Dermatitis—Gliclazide—type 2 diabetes mellitus	9.59e-05	0.000414	CcSEcCtD
Letrozole—Diarrhoea—Valsartan—type 2 diabetes mellitus	9.57e-05	0.000413	CcSEcCtD
Letrozole—Urticaria—Irbesartan—type 2 diabetes mellitus	9.55e-05	0.000413	CcSEcCtD
Letrozole—Headache—Gliclazide—type 2 diabetes mellitus	9.54e-05	0.000412	CcSEcCtD
Letrozole—Nervous system disorder—Ramipril—type 2 diabetes mellitus	9.52e-05	0.000411	CcSEcCtD
Letrozole—Abdominal pain—Irbesartan—type 2 diabetes mellitus	9.51e-05	0.000411	CcSEcCtD
Letrozole—Body temperature increased—Irbesartan—type 2 diabetes mellitus	9.51e-05	0.000411	CcSEcCtD
Letrozole—Tachycardia—Ramipril—type 2 diabetes mellitus	9.47e-05	0.000409	CcSEcCtD
Letrozole—Diarrhoea—Orlistat—type 2 diabetes mellitus	9.46e-05	0.000409	CcSEcCtD
Letrozole—Skin disorder—Ramipril—type 2 diabetes mellitus	9.42e-05	0.000407	CcSEcCtD
Letrozole—Hyperhidrosis—Ramipril—type 2 diabetes mellitus	9.38e-05	0.000405	CcSEcCtD
Letrozole—Feeling abnormal—Losartan—type 2 diabetes mellitus	9.32e-05	0.000403	CcSEcCtD
Letrozole—Gastrointestinal pain—Losartan—type 2 diabetes mellitus	9.25e-05	0.0004	CcSEcCtD
Letrozole—Dizziness—Valsartan—type 2 diabetes mellitus	9.25e-05	0.0004	CcSEcCtD
Letrozole—Anorexia—Ramipril—type 2 diabetes mellitus	9.25e-05	0.000399	CcSEcCtD
Letrozole—Dizziness—Orlistat—type 2 diabetes mellitus	9.14e-05	0.000395	CcSEcCtD
Letrozole—Asthenia—Metformin—type 2 diabetes mellitus	9.14e-05	0.000395	CcSEcCtD
Letrozole—Nausea—Gliclazide—type 2 diabetes mellitus	9.05e-05	0.000391	CcSEcCtD
Letrozole—Pruritus—Metformin—type 2 diabetes mellitus	9.01e-05	0.000389	CcSEcCtD
Letrozole—Urticaria—Losartan—type 2 diabetes mellitus	8.99e-05	0.000388	CcSEcCtD
Letrozole—Abdominal pain—Losartan—type 2 diabetes mellitus	8.95e-05	0.000386	CcSEcCtD
Letrozole—Body temperature increased—Losartan—type 2 diabetes mellitus	8.95e-05	0.000386	CcSEcCtD
Letrozole—Vomiting—Valsartan—type 2 diabetes mellitus	8.9e-05	0.000384	CcSEcCtD
Letrozole—Musculoskeletal discomfort—Ramipril—type 2 diabetes mellitus	8.84e-05	0.000382	CcSEcCtD
Letrozole—Rash—Valsartan—type 2 diabetes mellitus	8.82e-05	0.000381	CcSEcCtD
Letrozole—Dermatitis—Valsartan—type 2 diabetes mellitus	8.81e-05	0.000381	CcSEcCtD
Letrozole—Vomiting—Orlistat—type 2 diabetes mellitus	8.79e-05	0.00038	CcSEcCtD
Letrozole—Insomnia—Ramipril—type 2 diabetes mellitus	8.78e-05	0.000379	CcSEcCtD
Letrozole—Headache—Valsartan—type 2 diabetes mellitus	8.77e-05	0.000379	CcSEcCtD
Letrozole—Diarrhoea—Metformin—type 2 diabetes mellitus	8.72e-05	0.000377	CcSEcCtD
Letrozole—Rash—Orlistat—type 2 diabetes mellitus	8.72e-05	0.000377	CcSEcCtD
Letrozole—Paraesthesia—Ramipril—type 2 diabetes mellitus	8.71e-05	0.000376	CcSEcCtD
Letrozole—Dermatitis—Orlistat—type 2 diabetes mellitus	8.71e-05	0.000376	CcSEcCtD
Letrozole—Headache—Orlistat—type 2 diabetes mellitus	8.66e-05	0.000374	CcSEcCtD
Letrozole—Dyspnoea—Ramipril—type 2 diabetes mellitus	8.65e-05	0.000374	CcSEcCtD
Letrozole—Asthenia—Irbesartan—type 2 diabetes mellitus	8.63e-05	0.000373	CcSEcCtD
Letrozole—Somnolence—Ramipril—type 2 diabetes mellitus	8.63e-05	0.000373	CcSEcCtD
Letrozole—Dyspepsia—Ramipril—type 2 diabetes mellitus	8.54e-05	0.000369	CcSEcCtD
Letrozole—Pruritus—Irbesartan—type 2 diabetes mellitus	8.51e-05	0.000367	CcSEcCtD
Letrozole—Decreased appetite—Ramipril—type 2 diabetes mellitus	8.43e-05	0.000364	CcSEcCtD
Letrozole—Dizziness—Metformin—type 2 diabetes mellitus	8.43e-05	0.000364	CcSEcCtD
Letrozole—Gastrointestinal disorder—Ramipril—type 2 diabetes mellitus	8.38e-05	0.000362	CcSEcCtD
Letrozole—Fatigue—Ramipril—type 2 diabetes mellitus	8.37e-05	0.000361	CcSEcCtD
Letrozole—Nausea—Valsartan—type 2 diabetes mellitus	8.31e-05	0.000359	CcSEcCtD
Letrozole—Constipation—Ramipril—type 2 diabetes mellitus	8.3e-05	0.000358	CcSEcCtD
Letrozole—Diarrhoea—Irbesartan—type 2 diabetes mellitus	8.23e-05	0.000355	CcSEcCtD
Letrozole—Nausea—Orlistat—type 2 diabetes mellitus	8.21e-05	0.000355	CcSEcCtD
Letrozole—Asthenia—Losartan—type 2 diabetes mellitus	8.12e-05	0.000351	CcSEcCtD
Letrozole—Vomiting—Metformin—type 2 diabetes mellitus	8.1e-05	0.00035	CcSEcCtD
Letrozole—Rash—Metformin—type 2 diabetes mellitus	8.03e-05	0.000347	CcSEcCtD
Letrozole—Dermatitis—Metformin—type 2 diabetes mellitus	8.03e-05	0.000347	CcSEcCtD
Letrozole—Pruritus—Losartan—type 2 diabetes mellitus	8.01e-05	0.000346	CcSEcCtD
Letrozole—Feeling abnormal—Ramipril—type 2 diabetes mellitus	8e-05	0.000345	CcSEcCtD
Letrozole—Headache—Metformin—type 2 diabetes mellitus	7.98e-05	0.000345	CcSEcCtD
Letrozole—Dizziness—Irbesartan—type 2 diabetes mellitus	7.95e-05	0.000343	CcSEcCtD
Letrozole—Gastrointestinal pain—Ramipril—type 2 diabetes mellitus	7.93e-05	0.000343	CcSEcCtD
Letrozole—Diarrhoea—Losartan—type 2 diabetes mellitus	7.74e-05	0.000334	CcSEcCtD
Letrozole—Urticaria—Ramipril—type 2 diabetes mellitus	7.71e-05	0.000333	CcSEcCtD
Letrozole—Body temperature increased—Ramipril—type 2 diabetes mellitus	7.67e-05	0.000331	CcSEcCtD
Letrozole—Abdominal pain—Ramipril—type 2 diabetes mellitus	7.67e-05	0.000331	CcSEcCtD
Letrozole—Vomiting—Irbesartan—type 2 diabetes mellitus	7.65e-05	0.00033	CcSEcCtD
Letrozole—Rash—Irbesartan—type 2 diabetes mellitus	7.58e-05	0.000327	CcSEcCtD
Letrozole—Dermatitis—Irbesartan—type 2 diabetes mellitus	7.57e-05	0.000327	CcSEcCtD
Letrozole—Nausea—Metformin—type 2 diabetes mellitus	7.57e-05	0.000327	CcSEcCtD
Letrozole—Headache—Irbesartan—type 2 diabetes mellitus	7.53e-05	0.000325	CcSEcCtD
Letrozole—Dizziness—Losartan—type 2 diabetes mellitus	7.48e-05	0.000323	CcSEcCtD
Letrozole—Vomiting—Losartan—type 2 diabetes mellitus	7.19e-05	0.000311	CcSEcCtD
Letrozole—Nausea—Irbesartan—type 2 diabetes mellitus	7.14e-05	0.000308	CcSEcCtD
Letrozole—Rash—Losartan—type 2 diabetes mellitus	7.13e-05	0.000308	CcSEcCtD
Letrozole—Dermatitis—Losartan—type 2 diabetes mellitus	7.13e-05	0.000308	CcSEcCtD
Letrozole—Headache—Losartan—type 2 diabetes mellitus	7.09e-05	0.000306	CcSEcCtD
Letrozole—Asthenia—Ramipril—type 2 diabetes mellitus	6.96e-05	0.000301	CcSEcCtD
Letrozole—Pruritus—Ramipril—type 2 diabetes mellitus	6.86e-05	0.000297	CcSEcCtD
Letrozole—Nausea—Losartan—type 2 diabetes mellitus	6.72e-05	0.00029	CcSEcCtD
Letrozole—Diarrhoea—Ramipril—type 2 diabetes mellitus	6.64e-05	0.000287	CcSEcCtD
Letrozole—Dizziness—Ramipril—type 2 diabetes mellitus	6.42e-05	0.000277	CcSEcCtD
Letrozole—Vomiting—Ramipril—type 2 diabetes mellitus	6.17e-05	0.000266	CcSEcCtD
Letrozole—Rash—Ramipril—type 2 diabetes mellitus	6.12e-05	0.000264	CcSEcCtD
Letrozole—Dermatitis—Ramipril—type 2 diabetes mellitus	6.11e-05	0.000264	CcSEcCtD
Letrozole—Headache—Ramipril—type 2 diabetes mellitus	6.08e-05	0.000263	CcSEcCtD
Letrozole—Nausea—Ramipril—type 2 diabetes mellitus	5.76e-05	0.000249	CcSEcCtD
Letrozole—CYP19A1—Metabolism—CYTB—type 2 diabetes mellitus	4.93e-05	0.000926	CbGpPWpGaD
Letrozole—CYP3A4—Biological oxidations—MTR—type 2 diabetes mellitus	4.83e-05	0.000908	CbGpPWpGaD
Letrozole—CYP2A6—Metabolism—AK1—type 2 diabetes mellitus	4.81e-05	0.000904	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism—SRD5A1—type 2 diabetes mellitus	4.8e-05	0.000903	CbGpPWpGaD
Letrozole—CYP3A4—Biological oxidations—CYP11A1—type 2 diabetes mellitus	4.68e-05	0.000879	CbGpPWpGaD
Letrozole—CYP3A4—Metapathway biotransformation—CYP11A1—type 2 diabetes mellitus	4.62e-05	0.000867	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism—ACACA—type 2 diabetes mellitus	4.58e-05	0.000861	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism—HSD17B3—type 2 diabetes mellitus	4.58e-05	0.000861	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism—STAR—type 2 diabetes mellitus	4.58e-05	0.000861	CbGpPWpGaD
Letrozole—CYP19A1—Integrated Breast Cancer Pathway—EGFR—type 2 diabetes mellitus	4.45e-05	0.000836	CbGpPWpGaD
Letrozole—CYP2A6—Metabolism—SLC5A4—type 2 diabetes mellitus	4.44e-05	0.000835	CbGpPWpGaD
Letrozole—CYP2A6—Metabolism—MAT1A—type 2 diabetes mellitus	4.44e-05	0.000835	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism—ABCC8—type 2 diabetes mellitus	4.39e-05	0.000826	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism—CBS—type 2 diabetes mellitus	4.39e-05	0.000826	CbGpPWpGaD
Letrozole—CYP2A6—Metabolism—HBA2—type 2 diabetes mellitus	4.29e-05	0.000806	CbGpPWpGaD
Letrozole—CYP2A6—Metabolism—ND1—type 2 diabetes mellitus	4.29e-05	0.000806	CbGpPWpGaD
Letrozole—CYP2A6—Metabolism—ENPP1—type 2 diabetes mellitus	4.29e-05	0.000806	CbGpPWpGaD
Letrozole—CYP2A6—Metabolism—G6PC—type 2 diabetes mellitus	4.29e-05	0.000806	CbGpPWpGaD
Letrozole—CYP2A6—Metabolism—PPP1R3C—type 2 diabetes mellitus	4.29e-05	0.000806	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism—SLC5A2—type 2 diabetes mellitus	4.23e-05	0.000795	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism—COX2—type 2 diabetes mellitus	4.23e-05	0.000795	CbGpPWpGaD
Letrozole—CYP2A6—Metabolism—GCGR—type 2 diabetes mellitus	4.16e-05	0.000781	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism—NCOA6—type 2 diabetes mellitus	4.16e-05	0.000781	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism of lipids and lipoproteins—PPARGC1A—type 2 diabetes mellitus	4.15e-05	0.00078	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism—HSD11B1—type 2 diabetes mellitus	4.09e-05	0.000767	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism—UCP3—type 2 diabetes mellitus	4.09e-05	0.000767	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism—UCP2—type 2 diabetes mellitus	4.09e-05	0.000767	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism of lipids and lipoproteins—APOB—type 2 diabetes mellitus	3.96e-05	0.000744	CbGpPWpGaD
Letrozole—CYP2A6—Metabolism—CYTB—type 2 diabetes mellitus	3.92e-05	0.000737	CbGpPWpGaD
Letrozole—CYP2A6—Metabolism—OXCT1—type 2 diabetes mellitus	3.92e-05	0.000737	CbGpPWpGaD
Letrozole—CYP3A4—Biological oxidations—CYP2E1—type 2 diabetes mellitus	3.86e-05	0.000726	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism—PCK1—type 2 diabetes mellitus	3.84e-05	0.000722	CbGpPWpGaD
Letrozole—CYP2A6—Metabolism—SRD5A1—type 2 diabetes mellitus	3.82e-05	0.000718	CbGpPWpGaD
Letrozole—CYP3A4—Biological oxidations—CYP1A2—type 2 diabetes mellitus	3.82e-05	0.000718	CbGpPWpGaD
Letrozole—CYP3A4—Metapathway biotransformation—CYP2E1—type 2 diabetes mellitus	3.81e-05	0.000716	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism of lipids and lipoproteins—LPL—type 2 diabetes mellitus	3.78e-05	0.00071	CbGpPWpGaD
Letrozole—CYP3A4—Metapathway biotransformation—CYP1A2—type 2 diabetes mellitus	3.77e-05	0.000708	CbGpPWpGaD
Letrozole—CYP2A6—NRF2 pathway—TGFB1—type 2 diabetes mellitus	3.71e-05	0.000697	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism of lipids and lipoproteins—GPX1—type 2 diabetes mellitus	3.69e-05	0.000693	CbGpPWpGaD
Letrozole—CYP2A6—Metabolism—HSD17B3—type 2 diabetes mellitus	3.65e-05	0.000685	CbGpPWpGaD
Letrozole—CYP2A6—Metabolism—ACACA—type 2 diabetes mellitus	3.65e-05	0.000685	CbGpPWpGaD
Letrozole—CYP2A6—Metabolism—STAR—type 2 diabetes mellitus	3.65e-05	0.000685	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism—HK1—type 2 diabetes mellitus	3.6e-05	0.000676	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism of lipids and lipoproteins—CD36—type 2 diabetes mellitus	3.59e-05	0.000675	CbGpPWpGaD
Letrozole—CYP2A6—Metabolism—CBS—type 2 diabetes mellitus	3.5e-05	0.000657	CbGpPWpGaD
Letrozole—CYP2A6—Metabolism—ABCC8—type 2 diabetes mellitus	3.5e-05	0.000657	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism—HSD3B2—type 2 diabetes mellitus	3.47e-05	0.000653	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism—KCNJ11—type 2 diabetes mellitus	3.47e-05	0.000653	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism—LPA—type 2 diabetes mellitus	3.47e-05	0.000653	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism—GCKR—type 2 diabetes mellitus	3.47e-05	0.000653	CbGpPWpGaD
Letrozole—CYP2A6—Metabolism—SLC5A2—type 2 diabetes mellitus	3.37e-05	0.000632	CbGpPWpGaD
Letrozole—CYP2A6—Metabolism—COX2—type 2 diabetes mellitus	3.37e-05	0.000632	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism of lipids and lipoproteins—PPARA—type 2 diabetes mellitus	3.34e-05	0.000627	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism—ALDOB—type 2 diabetes mellitus	3.33e-05	0.000626	CbGpPWpGaD
Letrozole—CYP2A6—Metabolism—NCOA6—type 2 diabetes mellitus	3.31e-05	0.000621	CbGpPWpGaD
Letrozole—CYP2A6—Metabolism—UCP2—type 2 diabetes mellitus	3.25e-05	0.000611	CbGpPWpGaD
Letrozole—CYP2A6—Metabolism—UCP3—type 2 diabetes mellitus	3.25e-05	0.000611	CbGpPWpGaD
Letrozole—CYP2A6—Metabolism—HSD11B1—type 2 diabetes mellitus	3.25e-05	0.000611	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism of lipids and lipoproteins—AGT—type 2 diabetes mellitus	3.24e-05	0.000608	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism of lipids and lipoproteins—APOE—type 2 diabetes mellitus	3.17e-05	0.000595	CbGpPWpGaD
Letrozole—CYP19A1—Integrated Breast Cancer Pathway—AKT1—type 2 diabetes mellitus	3.15e-05	0.000593	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism of lipids and lipoproteins—APOA1—type 2 diabetes mellitus	3.13e-05	0.000589	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism—GLP1R—type 2 diabetes mellitus	3.1e-05	0.000582	CbGpPWpGaD
Letrozole—CYP2A6—Metabolism—PCK1—type 2 diabetes mellitus	3.06e-05	0.000574	CbGpPWpGaD
Letrozole—CYP3A4—Biological oxidations—GSTM1—type 2 diabetes mellitus	2.93e-05	0.00055	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism—SLC2A2—type 2 diabetes mellitus	2.89e-05	0.000543	CbGpPWpGaD
Letrozole—CYP3A4—Metapathway biotransformation—GSTM1—type 2 diabetes mellitus	2.89e-05	0.000542	CbGpPWpGaD
Letrozole—CYP2A6—Metabolism—HK1—type 2 diabetes mellitus	2.86e-05	0.000538	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism—CPT1A—type 2 diabetes mellitus	2.83e-05	0.000532	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism—MTR—type 2 diabetes mellitus	2.83e-05	0.000532	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism—NAMPT—type 2 diabetes mellitus	2.78e-05	0.000522	CbGpPWpGaD
Letrozole—CYP2A6—Metabolism—KCNJ11—type 2 diabetes mellitus	2.77e-05	0.000519	CbGpPWpGaD
Letrozole—CYP2A6—Metabolism—GCKR—type 2 diabetes mellitus	2.77e-05	0.000519	CbGpPWpGaD
Letrozole—CYP2A6—Metabolism—LPA—type 2 diabetes mellitus	2.77e-05	0.000519	CbGpPWpGaD
Letrozole—CYP2A6—Metabolism—HSD3B2—type 2 diabetes mellitus	2.77e-05	0.000519	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism of lipids and lipoproteins—PPARG—type 2 diabetes mellitus	2.76e-05	0.000519	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism—HBA1—type 2 diabetes mellitus	2.76e-05	0.000518	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism—LIPC—type 2 diabetes mellitus	2.76e-05	0.000518	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism—GCK—type 2 diabetes mellitus	2.76e-05	0.000518	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism—CYP11A1—type 2 diabetes mellitus	2.74e-05	0.000515	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism—SLC9A1—type 2 diabetes mellitus	2.69e-05	0.000506	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism—CETP—type 2 diabetes mellitus	2.66e-05	0.0005	CbGpPWpGaD
Letrozole—CYP2A6—Metabolism—ALDOB—type 2 diabetes mellitus	2.65e-05	0.000498	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism of lipids and lipoproteins—ALB—type 2 diabetes mellitus	2.48e-05	0.000466	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism—PSMD6—type 2 diabetes mellitus	2.48e-05	0.000465	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism—SREBF1—type 2 diabetes mellitus	2.48e-05	0.000465	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism—SNAP25—type 2 diabetes mellitus	2.48e-05	0.000465	CbGpPWpGaD
Letrozole—CYP2A6—Metabolism—GLP1R—type 2 diabetes mellitus	2.46e-05	0.000463	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism—CTGF—type 2 diabetes mellitus	2.43e-05	0.000456	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism—HMGCR—type 2 diabetes mellitus	2.41e-05	0.000452	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism of lipids and lipoproteins—PIK3R1—type 2 diabetes mellitus	2.37e-05	0.000446	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism—ADRA2A—type 2 diabetes mellitus	2.36e-05	0.000443	CbGpPWpGaD
Letrozole—CYP2A6—Metabolism—SLC2A2—type 2 diabetes mellitus	2.3e-05	0.000432	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism—CYP2E1—type 2 diabetes mellitus	2.26e-05	0.000425	CbGpPWpGaD
Letrozole—CYP2A6—Metabolism—CPT1A—type 2 diabetes mellitus	2.25e-05	0.000423	CbGpPWpGaD
Letrozole—CYP2A6—Metabolism—MTR—type 2 diabetes mellitus	2.25e-05	0.000423	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism—CYP1A2—type 2 diabetes mellitus	2.24e-05	0.000421	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism—SLC2A1—type 2 diabetes mellitus	2.24e-05	0.000421	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—BHMT—type 2 diabetes mellitus	2.23e-05	0.000419	CbGpPWpGaD
Letrozole—CYP2A6—Metabolism—NAMPT—type 2 diabetes mellitus	2.21e-05	0.000415	CbGpPWpGaD
Letrozole—CYP2A6—Metabolism—LIPC—type 2 diabetes mellitus	2.2e-05	0.000413	CbGpPWpGaD
Letrozole—CYP2A6—Metabolism—HBA1—type 2 diabetes mellitus	2.2e-05	0.000413	CbGpPWpGaD
Letrozole—CYP2A6—Metabolism—GCK—type 2 diabetes mellitus	2.2e-05	0.000413	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism—CYP3A4—type 2 diabetes mellitus	2.18e-05	0.00041	CbGpPWpGaD
Letrozole—CYP2A6—Metabolism—CYP11A1—type 2 diabetes mellitus	2.18e-05	0.00041	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism of lipids and lipoproteins—PTGS2—type 2 diabetes mellitus	2.17e-05	0.000408	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism—GCG—type 2 diabetes mellitus	2.15e-05	0.000403	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism—SLC2A4—type 2 diabetes mellitus	2.15e-05	0.000403	CbGpPWpGaD
Letrozole—CYP2A6—Metabolism—SLC9A1—type 2 diabetes mellitus	2.14e-05	0.000403	CbGpPWpGaD
Letrozole—CYP2A6—Metabolism—CETP—type 2 diabetes mellitus	2.12e-05	0.000398	CbGpPWpGaD
Letrozole—CYP2A6—Metabolism—SNAP25—type 2 diabetes mellitus	1.97e-05	0.00037	CbGpPWpGaD
Letrozole—CYP2A6—Metabolism—SREBF1—type 2 diabetes mellitus	1.97e-05	0.00037	CbGpPWpGaD
Letrozole—CYP2A6—Metabolism—PSMD6—type 2 diabetes mellitus	1.97e-05	0.00037	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—AANAT—type 2 diabetes mellitus	1.95e-05	0.000367	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—PTGDS—type 2 diabetes mellitus	1.95e-05	0.000367	CbGpPWpGaD
Letrozole—CYP2A6—Metabolism—CTGF—type 2 diabetes mellitus	1.93e-05	0.000363	CbGpPWpGaD
Letrozole—CYP2A6—Metabolism—HMGCR—type 2 diabetes mellitus	1.92e-05	0.00036	CbGpPWpGaD
Letrozole—CYP2A6—Metabolism—ADRA2A—type 2 diabetes mellitus	1.88e-05	0.000352	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—GPD2—type 2 diabetes mellitus	1.85e-05	0.000348	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—CDO1—type 2 diabetes mellitus	1.85e-05	0.000348	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism—GNB3—type 2 diabetes mellitus	1.85e-05	0.000347	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism—PPARGC1A—type 2 diabetes mellitus	1.85e-05	0.000347	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism—HMOX1—type 2 diabetes mellitus	1.84e-05	0.000346	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism—CAT—type 2 diabetes mellitus	1.82e-05	0.000341	CbGpPWpGaD
Letrozole—CYP2A6—Metabolism—CYP2E1—type 2 diabetes mellitus	1.8e-05	0.000338	CbGpPWpGaD
Letrozole—CYP2A6—Metabolism—CYP1A2—type 2 diabetes mellitus	1.78e-05	0.000335	CbGpPWpGaD
Letrozole—CYP2A6—Metabolism—SLC2A1—type 2 diabetes mellitus	1.78e-05	0.000335	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—AK1—type 2 diabetes mellitus	1.77e-05	0.000332	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism—APOB—type 2 diabetes mellitus	1.76e-05	0.000331	CbGpPWpGaD
Letrozole—CYP2A6—Metabolism—CYP3A4—type 2 diabetes mellitus	1.74e-05	0.000326	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism—GSTM1—type 2 diabetes mellitus	1.72e-05	0.000322	CbGpPWpGaD
Letrozole—CYP2A6—Metabolism—GCG—type 2 diabetes mellitus	1.71e-05	0.000321	CbGpPWpGaD
Letrozole—CYP2A6—Metabolism—SLC2A4—type 2 diabetes mellitus	1.71e-05	0.000321	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism—LPL—type 2 diabetes mellitus	1.68e-05	0.000316	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism—ADCY5—type 2 diabetes mellitus	1.65e-05	0.00031	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism—GPX1—type 2 diabetes mellitus	1.64e-05	0.000309	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—SLC5A4—type 2 diabetes mellitus	1.63e-05	0.000306	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—MAT1A—type 2 diabetes mellitus	1.63e-05	0.000306	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism—CD36—type 2 diabetes mellitus	1.6e-05	0.000301	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism—PPP2CA—type 2 diabetes mellitus	1.58e-05	0.000297	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—G6PC—type 2 diabetes mellitus	1.57e-05	0.000296	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—PPP1R3C—type 2 diabetes mellitus	1.57e-05	0.000296	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—ENPP1—type 2 diabetes mellitus	1.57e-05	0.000296	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—HBA2—type 2 diabetes mellitus	1.57e-05	0.000296	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—ND1—type 2 diabetes mellitus	1.57e-05	0.000296	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—GCGR—type 2 diabetes mellitus	1.52e-05	0.000286	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism—MTHFR—type 2 diabetes mellitus	1.52e-05	0.000285	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism—PPARA—type 2 diabetes mellitus	1.49e-05	0.000279	CbGpPWpGaD
Letrozole—CYP2A6—Metabolism—GNB3—type 2 diabetes mellitus	1.47e-05	0.000277	CbGpPWpGaD
Letrozole—CYP2A6—Metabolism—PPARGC1A—type 2 diabetes mellitus	1.47e-05	0.000277	CbGpPWpGaD
Letrozole—CYP2A6—Metabolism—HMOX1—type 2 diabetes mellitus	1.47e-05	0.000275	CbGpPWpGaD
Letrozole—CYP2A6—Metabolism—CAT—type 2 diabetes mellitus	1.45e-05	0.000272	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism—AGT—type 2 diabetes mellitus	1.44e-05	0.000271	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—CYTB—type 2 diabetes mellitus	1.44e-05	0.00027	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—OXCT1—type 2 diabetes mellitus	1.44e-05	0.00027	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism—CALM1—type 2 diabetes mellitus	1.42e-05	0.000266	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism—APOE—type 2 diabetes mellitus	1.41e-05	0.000265	CbGpPWpGaD
Letrozole—CYP2A6—Metabolism—APOB—type 2 diabetes mellitus	1.4e-05	0.000264	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—SRD5A1—type 2 diabetes mellitus	1.4e-05	0.000263	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism—APOA1—type 2 diabetes mellitus	1.4e-05	0.000262	CbGpPWpGaD
Letrozole—CYP2A6—Metabolism—GSTM1—type 2 diabetes mellitus	1.37e-05	0.000257	CbGpPWpGaD
Letrozole—CYP2A6—Metabolism—LPL—type 2 diabetes mellitus	1.34e-05	0.000252	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—HSD17B3—type 2 diabetes mellitus	1.34e-05	0.000251	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—ACACA—type 2 diabetes mellitus	1.34e-05	0.000251	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—STAR—type 2 diabetes mellitus	1.34e-05	0.000251	CbGpPWpGaD
Letrozole—CYP2A6—Metabolism—ADCY5—type 2 diabetes mellitus	1.31e-05	0.000247	CbGpPWpGaD
Letrozole—CYP2A6—Metabolism—GPX1—type 2 diabetes mellitus	1.31e-05	0.000246	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—CBS—type 2 diabetes mellitus	1.28e-05	0.000241	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—ABCC8—type 2 diabetes mellitus	1.28e-05	0.000241	CbGpPWpGaD
Letrozole—CYP2A6—Metabolism—CD36—type 2 diabetes mellitus	1.27e-05	0.000239	CbGpPWpGaD
Letrozole—CYP2A6—Metabolism—PPP2CA—type 2 diabetes mellitus	1.26e-05	0.000236	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—COX2—type 2 diabetes mellitus	1.23e-05	0.000232	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—SLC5A2—type 2 diabetes mellitus	1.23e-05	0.000232	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism—PPARG—type 2 diabetes mellitus	1.23e-05	0.000231	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—NCOA6—type 2 diabetes mellitus	1.21e-05	0.000228	CbGpPWpGaD
Letrozole—CYP2A6—Metabolism—MTHFR—type 2 diabetes mellitus	1.21e-05	0.000227	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism—INS—type 2 diabetes mellitus	1.21e-05	0.000227	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—UCP2—type 2 diabetes mellitus	1.19e-05	0.000224	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—UCP3—type 2 diabetes mellitus	1.19e-05	0.000224	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—HSD11B1—type 2 diabetes mellitus	1.19e-05	0.000224	CbGpPWpGaD
Letrozole—CYP2A6—Metabolism—PPARA—type 2 diabetes mellitus	1.18e-05	0.000222	CbGpPWpGaD
Letrozole—CYP2A6—Metabolism—AGT—type 2 diabetes mellitus	1.15e-05	0.000215	CbGpPWpGaD
Letrozole—CYP2A6—Metabolism—CALM1—type 2 diabetes mellitus	1.13e-05	0.000212	CbGpPWpGaD
Letrozole—CYP2A6—Metabolism—APOE—type 2 diabetes mellitus	1.12e-05	0.000211	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—PCK1—type 2 diabetes mellitus	1.12e-05	0.000211	CbGpPWpGaD
Letrozole—CYP2A6—Metabolism—APOA1—type 2 diabetes mellitus	1.11e-05	0.000209	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism—ALB—type 2 diabetes mellitus	1.11e-05	0.000208	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism—PIK3R1—type 2 diabetes mellitus	1.06e-05	0.000199	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism—NOS3—type 2 diabetes mellitus	1.06e-05	0.000199	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—HK1—type 2 diabetes mellitus	1.05e-05	0.000197	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—GCKR—type 2 diabetes mellitus	1.01e-05	0.00019	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—HSD3B2—type 2 diabetes mellitus	1.01e-05	0.00019	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—KCNJ11—type 2 diabetes mellitus	1.01e-05	0.00019	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—LPA—type 2 diabetes mellitus	1.01e-05	0.00019	CbGpPWpGaD
Letrozole—CYP2A6—Metabolism—PPARG—type 2 diabetes mellitus	9.79e-06	0.000184	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—ALDOB—type 2 diabetes mellitus	9.72e-06	0.000183	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism—PTGS2—type 2 diabetes mellitus	9.67e-06	0.000182	CbGpPWpGaD
Letrozole—CYP2A6—Metabolism—INS—type 2 diabetes mellitus	9.6e-06	0.00018	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—GLP1R—type 2 diabetes mellitus	9.04e-06	0.00017	CbGpPWpGaD
Letrozole—CYP2A6—Metabolism—ALB—type 2 diabetes mellitus	8.8e-06	0.000165	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—SLC2A2—type 2 diabetes mellitus	8.44e-06	0.000158	CbGpPWpGaD
Letrozole—CYP2A6—Metabolism—PIK3R1—type 2 diabetes mellitus	8.42e-06	0.000158	CbGpPWpGaD
Letrozole—CYP2A6—Metabolism—NOS3—type 2 diabetes mellitus	8.42e-06	0.000158	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—MTR—type 2 diabetes mellitus	8.26e-06	0.000155	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—CPT1A—type 2 diabetes mellitus	8.26e-06	0.000155	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—NAMPT—type 2 diabetes mellitus	8.1e-06	0.000152	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—LIPC—type 2 diabetes mellitus	8.05e-06	0.000151	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—HBA1—type 2 diabetes mellitus	8.05e-06	0.000151	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—GCK—type 2 diabetes mellitus	8.05e-06	0.000151	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—CYP11A1—type 2 diabetes mellitus	8e-06	0.00015	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—SLC9A1—type 2 diabetes mellitus	7.86e-06	0.000148	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—CETP—type 2 diabetes mellitus	7.77e-06	0.000146	CbGpPWpGaD
Letrozole—CYP2A6—Metabolism—PTGS2—type 2 diabetes mellitus	7.7e-06	0.000145	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—SREBF1—type 2 diabetes mellitus	7.22e-06	0.000136	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—PSMD6—type 2 diabetes mellitus	7.22e-06	0.000136	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—SNAP25—type 2 diabetes mellitus	7.22e-06	0.000136	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—CTGF—type 2 diabetes mellitus	7.09e-06	0.000133	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—HMGCR—type 2 diabetes mellitus	7.03e-06	0.000132	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—ADRA2A—type 2 diabetes mellitus	6.88e-06	0.000129	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—CYP2E1—type 2 diabetes mellitus	6.61e-06	0.000124	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—CYP1A2—type 2 diabetes mellitus	6.53e-06	0.000123	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—SLC2A1—type 2 diabetes mellitus	6.53e-06	0.000123	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—GCG—type 2 diabetes mellitus	6.26e-06	0.000118	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—SLC2A4—type 2 diabetes mellitus	6.26e-06	0.000118	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—PPARGC1A—type 2 diabetes mellitus	5.4e-06	0.000101	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—GNB3—type 2 diabetes mellitus	5.4e-06	0.000101	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—HMOX1—type 2 diabetes mellitus	5.37e-06	0.000101	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—CAT—type 2 diabetes mellitus	5.3e-06	9.96e-05	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—APOB—type 2 diabetes mellitus	5.15e-06	9.67e-05	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—GSTM1—type 2 diabetes mellitus	5.01e-06	9.41e-05	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—LPL—type 2 diabetes mellitus	4.91e-06	9.23e-05	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism—AKT1—type 2 diabetes mellitus	4.86e-06	9.13e-05	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—ADCY5—type 2 diabetes mellitus	4.81e-06	9.04e-05	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—GPX1—type 2 diabetes mellitus	4.79e-06	9.01e-05	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—CD36—type 2 diabetes mellitus	4.67e-06	8.77e-05	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—PPP2CA—type 2 diabetes mellitus	4.61e-06	8.66e-05	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—MTHFR—type 2 diabetes mellitus	4.43e-06	8.31e-05	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—PPARA—type 2 diabetes mellitus	4.34e-06	8.15e-05	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—AGT—type 2 diabetes mellitus	4.2e-06	7.9e-05	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—CALM1—type 2 diabetes mellitus	4.13e-06	7.77e-05	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—APOE—type 2 diabetes mellitus	4.12e-06	7.74e-05	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—APOA1—type 2 diabetes mellitus	4.07e-06	7.65e-05	CbGpPWpGaD
Letrozole—CYP2A6—Metabolism—AKT1—type 2 diabetes mellitus	3.87e-06	7.27e-05	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—PPARG—type 2 diabetes mellitus	3.59e-06	6.74e-05	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—INS—type 2 diabetes mellitus	3.52e-06	6.61e-05	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—ALB—type 2 diabetes mellitus	3.23e-06	6.06e-05	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—PIK3R1—type 2 diabetes mellitus	3.09e-06	5.8e-05	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—NOS3—type 2 diabetes mellitus	3.09e-06	5.8e-05	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—PTGS2—type 2 diabetes mellitus	2.82e-06	5.3e-05	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—AKT1—type 2 diabetes mellitus	1.42e-06	2.66e-05	CbGpPWpGaD
